glutathione and targeting cancer cells Glutathione-dependent degradation of SMARCA2/4 for targeted lung therapy with improved selectivity Genetic architecture of the Format:Audio Research Bundle
Pay in 4 interest-free payments of $5.71 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3